|Bid||0.290 x 0|
|Ask||0.295 x 0|
|Day's Range||0.285 - 0.295|
|52 Week Range||0.221 - 0.465|
|Beta (3Y Monthly)||-0.06|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
March 18 (Reuters) - Regent Pacific Group Ltd: * ANNOUNCES SETTLEMENT OF AUSTRALIAN TAXATION DISPUTE AND OPERATIONS UPDATE * ENTERED SETTLEMENT AGREEMENT WITH AUSTRALIAN TAXATION OFFICE IN RESPECT OF DISPUTE ...
The big shareholder groups in Regent Pacific Group Limited (HKG:575) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders Read More...
Dec 21 (Reuters) - Regent Pacific Group Ltd: * UNIT ENTERED INTO A LICENCE AGREEMENT WITH ORIENT EUROPHARMA * PURSUANT TO LICENCE AGREEMENT, GROUP, ACTING THROUGH SOLUTIONS, WILL BE ELIGIBLE TO RECEIVE ...
Dec 3 (Reuters) - Regent Pacific Group Ltd: * ANNOUNCES LICENCE AGREEMENT WITH WANBANG PHARMACEUTICAL MARKETING AND DISTRIBUTION CO LTD FOR LAUNCH OF FORTACIN IN PRC * REGENT PACIFIC TO RECEIVE UP TO US$13 ...
Nov 6 (Reuters) - Regent Pacific Group Ltd: * REGISTERED FORTACINTM IN HONG KONG WITH HONG KONG DRUG OFFICE Source text for Eikon: Further company coverage:
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Regent Pacific Group Limited (HKG:575), as the company does not have to adhere to strict debt covenants. However, it alsoRead More...
Aug 24 (Reuters) - Regent Pacific Group Ltd: * HY LOSS ATTRIBUTABLE $14.3 MILLION VERSUS LOSS OF $19 MILLION Source text for Eikon: Further company coverage: